Lu Huang

Prof. Lu Huang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YLYi Lao
Yi Lao
TLTaidong Li
Taidong Li
XXXin Xie
Xin Xie
KCKangbiao Chen
Kangbiao Chen
MLMing Li
Ming Li
LHLu Huang
Lu Huang
Background: MicroRNA-195-3p (miR-195-3p) plays an important role in some tumors, but its role in LUAD is unclear. This study explored the expression of miR-195-3p in LUAD and the relationship between the expression of miR-195-3p and the clinical and prognostic characteristics of LUAD patients. Methods: MiR-195-3p expression and clinical information of LUAD patients were obtained from The Cancer Genome Atlas (TCGA). Kruskal–Wallis test, Wilcoxon signed rank test, logistic regression, and Cox regression were used to assess the relationship between the expression level of miR-195-3p and clinical features in LUAD tissues. Kaplan–Meier survival curves were used to analyze the effect of miR-195-3p expression levels on the prognosis of LUAD patients. Target genes of miR-195-3p were predicted by several software. GO (Gene Ontology), KEGG (Kyoto Encyclopedia of Genes and Genomes), and immune infiltration analysis were used to analyze the possible regulatory network of miR-195-3p. Results: Compared with normal lung tissue, miR-195-3p is down expressed in LUAD tissue (P < 0.001). The low miR-195-3p expression in LUAD was significantly associated with N stage (P = 0.046), pathologic stage (P = 0.011), and gender (P = 0.010). Low miR-195-3p expression predicted a poorer overall survival (HR: 0.60; 95% CI: 0.45– 0.81; P = 0.001) and disease-specific survival (HR: 0.55; 95% CI: 0.37– 0.80; P = 0.002). The expression of miR-195-3p (HR: 0.488; 95% CI: 0.304– 0.784; P = 0.003) was independently correlated with OS in LUAD patients. High expression of miR-195-3p genes, including ABCC2, AGMAT, ARNTL2, ATP6V0A4, CDC25A, CDK1, FAM111B, GJB2, GRIP1, HMGA2, HOXA9, KIF14, SYT2, and TFAP2A, were associated with poor OS in LUAD. GO and KEGG analysis suggested that miR-195-3p was related to the phagosome pathway. MiR-195-3p may promote the function of B cells, dendritic cells, eosinophils, immature dendritic cells, macrophages, Mast cells, NK cells, plasmacytoid dendritic cells, and follicular helper T cells. Conclusion: Low miR-195-3p expression is significantly associated with poor survival in LUAD, which may be a promising prognostic biomarker for LUAD.

9 December 2024 in ACS Omega
Verified
Journal Article
Open access
KCKangbiao Chen
Kangbiao Chen
RZRui Zhou
Rui Zhou
GZGaofeng Zhu
Gaofeng Zhu
LTLei Tang
Lei Tang
LHLu Huang
Lu Huang
QHQing He
Qing He
A transition metal-free domino Michael/SN2/aromatization annulation of 2-pyridylacetates with bromonitroolefins has been developed. A wide range of substrates containing various substituted groups was compatible with the present methodology and afforded functionalized indolizines with moderate to excellent yield (up to 99% yield). In addition, the potential practicality of the method stood out through scale-up reactions and further transformations to other valuable compounds. In our view, this study is an essential complement for the rapid construction of indolizine derivatives through a metal-free strategy.

18 July 2025 in PLOS ONE
Verified
Journal Article
Open access
YWYongling Wang
Yongling Wang
ZYZan Yuan
Zan Yuan
YLYi Lao
Yi Lao
JHJiangtao He
Jiangtao He
SMShufen Mo
Shufen Mo
LHLu Huang
Lu Huang
Background: The exact mechanisms driving colorectal cancer (CRC) are yet to be fully elucidated. This study aims to confirm the reliability of a prognostic model for colon adenocarcinoma (COAD) by analyzing the varied expression levels of Glycolysis & Pyroptosis-Related Differentially Expressed Genes (G&PRDEGs) in COAD using bioinformatics tools. Methods: We retrieved gene expression data and clinical details for COAD patients from the Cancer Genome Atlas (TCGA) database. These data were analyzed to categorize the samples into pyroptosis-positive and pyroptosis-negative groups based on their expression of G&PRDEGs. A prognostic model for COAD was then developed using LASSO Cox regression analysis, focusing on these differentially expressed genes (DEGs). Kaplan-Meier curves were plotted to assess the differences in survival between the two groups. Furthermore, we conducted multivariate Cox regression analyses to evaluate the influence of clinical parameters and model-derived risk scores. Analyses of pathway enrichment were performed using R software, alongside single-sample gene-set enrichment analysis (ssGSEA) to explore the role of immune cells and functions associated with G&PRDEGs. Results: A predictive model was developed using 53 G&PRDEGs that were expressed differentially. An examination of survival rates revealed that the high-risk groups exhibited a noticeably diminished overall survival (OS) in comparison to the low-risk groups in the TCGA database (P < 0.001). An examination of the receiver operating characteristic (ROC) curve indicated that the risk score effectively predicted outcomes at 1, 3, and 5 years, with a space beneath the curve greater than 0.7. The risk score significantly affected the survival of COAD sufferers in the TCGA database, on the basis of the multivariate Cox regression analysis. The high-risk groups had a hazard ratio (HR) of 3.988 (95% CI 2.865 ~ 5.551, P < 0.001) in contrast to the low-risk groups. Examinations of enrichment identified an increase in the expression of DEGs in the high-risk groups, in contrast to the low-risk cohort, on the basis of the TCGA database. SsGSEA revealed elevated levels of immune cell soakage in the high-risk groups in contrast to the low-risk groups. Conclusion: The COAD prognosis model, developed using G&PRDEGs, exhibits predictive capability for the prognosis of COAD sufferers and offers utility in prognostic analysis for COAD sufferers.